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Basal cell carcinoma is the most commonly seen nonmelanoma skin cancer which is rarely encountered in the childhood period.
An 11-year old child was admitted to our clinic due to an erythematous and a slightly pigmented lesion with a 3 × 4cm diameter
onhisposteriorscalp.Macroscopically,thelesionwasexcisedwitha10mmsafetymargin.Pathologicexaminationrevealedabasal
cell carcinoma. No symptoms or signs of a syndrome were observed both in the patient and his family.
1.Introduction
Non-melanoma skin cancers appear to be the most often
malignant tumors. Basal cell carcinoma (BCC) accounts for
75%ofnon-melonomaskincancersandpeaksintheseventh
decade [1]. Although it is frequent in the elderly, BCC is
extremely rare in children under 15 years of age. Basal cell
carcinoma seen in the pediatric age group is associated with
inherited syndromes like basal cell nevus syndrome, xero-
derma pigmentosum, Bazex syndrome, vitiligo, albinism,
and congenital lesions like nevus sebaceous. High-dose
radiotherapy has been deﬁned as a risk factor as well. Severe
or increased sun exposure has been most often implicated in
theetiologyofnongeneticBCC[2–6].Ultravioletraysinduce
DNA damage leading to overexpression of the oncogens
together with the depression of tumor suppressor genes
(Sonic Hedgehog and p53) [7]. Other than the ionizing
radiation, arsenicals and polyaromatic hydrocarbons play a
role in etiology as well [5].
2.Case
An 11-year-old boy was admitted to our clinic with the com-
plaint of a lesion of 15-month duration on the hairy scalp.
Physical examination revealed an erythematous, slightly
pigmented plaque lesion approximately 3×4cm in diameter
on the posterior scalp (Figure 1). Excisional biopsy was
done with a 10mm surgical margin. On histopathologic
examination, there were typical nodular basal cell carcinoma
tumor islands with ulceration localized in the dermis.
Asymmetrically growing solid nodules in the dermis with
connections to epidermis at some zones were seen. Frequent
mitoses were noted as well. Retraction artefact between
tumor nodules and the stroma were visualized. Adenoid
diﬀerentiation and pigmentation were observed, as well
(Figure 2). No recurrence was noted during the sixteen-
month followup of the patient. No other signs or symptoms
of syndromes have been encountered in the patient and his
family. Any particularrisk factors forBCC development have
not been documented.
3. Discussion
In a large study of 36207 children done by De la Luz
Orozco-Covarrubias et al. [4], 53 types of skin tumors
were demostrated in which 36 were primary and 17 were
metastatic. Among these 36 primary tumors, only 5 cases
were BCC (13%). The incidence of BCC was only 1.9 in
10,000 patients. In another wide series of 6264 chilhood
cancers, 21 primary malignant skin tumors were diagnosed2 Journal of Skin Cancer
Figure 1: Macroscopic appearance of the lesion on the scalp.
Figure 2: Large magniﬁcation showing the intersection area of the
normal dermis stroma and the stroma caused by the tumor on
the right, and the typical palisadic arrangement of the cells on the
peripheral tumor on the left (H and E stain; original magniﬁcation:
x200).
and only 9.5% of them were reported to be BCC [5]. In
an article published in 2007, 107 idiopathic BCC cases
were reviewed and the head was (90.4%) the most often
site. Most common localization was cheek in the head
and neck region. The scalp accounted for 14.5% of the
cases. In the same study, nodular, adenocystic, follicular
nodulocystic, superﬁcial, and typical nonaggresive variants
were reported to constitute 80% of all cases. Remaining cases
were deﬁned as sclerosing, inﬁltrating, and basosquamous
type of aggressive variants. 18% of recurrence was reported
in that study. Any correlation between the histopathologic
variant and the prognosis was not mentioned [6]. In the case
we presented, localization was the posterior scalp and the
histopathologic variant was nodular.
BCC is most commonly seen in patients with light-
colored hair and skin. Major risk factors for BCC are
increased sun exposure, vitiligo-albinism, immunosuppres-
sion (AIDS, drug use due to organ transplantation), and
radiation. Genetic factors are important as well [4–6]. Most
likely cause in our case was supposed to be sun exposure.
Other major risk factors of BCC were not encountered at all.
Gorlin-Goltz syndrome (basal cell nevus syndrome) is an
autosomal dominant inherited disorder, which is character-
ized by multiple basal cell carcinoma, maxillary keratocysts,
multiple pits of palms and soles, ectopic calciﬁcation of
cranial membranes, cysts of jaw, and musculoskeletal mal-
formations [8]. Xeroderma pigmentosum is an autosomal
recessive inherited disorder, which is characterized by sun
sensitivity, increased freckling, pigmentation, and dryness of
sun-exposed skin and increased risk of cutaneous neoplasms
(BCC, squamous cell carcinoma, and melanoma) [9]. No
family history was observed in our case. In additon, no
genodermatosis signs have been seen other than the skin
pathologies.
Nevus sebaceous should be kept in mind for a tumor
on scalp localization at infancy, childhood, and puberty
periods. Sebaceous glands in nevus sebaceous follow the
pattern of normal sebaceous glands during these periods.
In pubertal age, nevus sebaceous histologically manifests as
large numbers of mature sebaceous glands overlying papil-
lomatous epithelial hyperplasia, small hair structures, and
ectopic apocrine glands in dermis. In the presented case, any
features of nevus sebaseous or trichoepithelioma could not
be seen at all. The lesion was diagnosed as idiopathic form of
basal cell carcinoma, both clinically and histopathologically.
Electrodessication, curettage, topical chemotherapy (5-
ﬂuorouracil, methotrexate, bleomycin, and interferon),
radiotherapy, radium plate or radon mould might be
used to treat lesions. Excision with or without the Mohs
micrographic technique is the main treatment of basal cell
carcinoma.TheMohstechniqueisveryusefulincosmetically
sensitive regions such as the nose, lips, eyelids, and ears.
After resection, the defects are generally closed primarily.
Nevertheless skin grafts and ﬂaps (range from local ﬂaps to
free tissue transfer) may be used to repair for larger defects
[10, 11].
In view of the information so far known, increase in the
childhood BCC incidence in recent years should be ascribed
to high-level UV radiation exposure [2]. It is not diﬃcult
to estimate that the diseases associated with increased UV
radiation exposure will rise in the future. Given that the
age of BCC appearance is decreased, this tumor should be
considered in the diﬀerential diagnosis of childhood skin
lesions.
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